-The Times of India MUMBAI: Certain medicines are being aggressively marketed in India despite inadequate evidence of safety and efficacy, putting patients at risk, said reputed medical journal Lancet. Highlighting weak regulation and monitoring of the domestic drug industry, three recently-introduced medicines are being prescribed and sold though there is a lack of rigorous trials on crucial safety and efficacy parameters. The pharmaceutical industry in India should face the same stringent regulations...

-The Hindu Business Line Transparency required on data concerning Clinical Trials and procurement of drugs Earlier this year, rotavirus vaccine 116E was launched with much fanfare. The celebration of this vaccine that would protect infants against rotavirus gastroenteritis was on two counts. It was developed locally and its price was pegged at $1, less than competing rotavirus vaccines that sell in the country. But the rollout of this indigenous vaccine as part of...

-Economic and Political Weekly The health ministry's move on HPV vaccine feasibility is ill-advised. The union health ministry has asked the National Technical Advisory Group on Immunisation (NTAGI) to examine the feasibility of introducing the Human Papillomavirus (HPV) vaccine in the country’s universal immunisation programme. The NTAGI has been given three months for this task. The HPV vaccine, which is supposed to protect against cervical cancer in girls and women, is generally...

-The Telegraph New Delhi: The Indian government will study 100,000 infants to evaluate a home-grown vaccine against rotavirus gastroenteritis, released this month amid concerns raised by a paediatrician about the risk of an intestinal side-effect. Doctors from Delhi, Pune and the Christian Medical College, Vellore, will measure -- through what could be India's largest study - any vaccine-associated risk of intussusception, a disorder in which the intestine telescopes into itself and may...

-The Hindu The challenge for the Modi government is to evaluate what works in development programming before making large spending decisions Governments in India have always launched big-ticket social development programmes with ambitious goals. The Narendra Modi government is no exception. Swachh Bharat Abhiyan aims to make India open defecation-free by 2019. The Pradhan Mantri Jan Dhan Yojana's financial inclusion programme set a target of opening 10 crore bank accounts by January...